Previous 10 | Next 10 |
Via a reverse merger, leading U.S. cannabis producer MM Enterprises, renamed MedMen Enterprises, will begin trading today on the Canadian Securities Exchange (CSE) under the symbol "MMEN." More news on: Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutics Inc., Medical Marij...
IRVINE, CA, May 25, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the Company’s participation in the 2018 Global Health Catalyst Summit. The Summit is being held today, May 25th, t...
Toronto-based investment shop Eight Capital is bullish on M&A activity in the marijuana space. Analyst Graeme Kreindler says the deal pace should ramp up considerably since the cannabis industry is in its infancy. More news on: Aphria Inc., Aurora Cannabis Inc., Hydropothecary Corp, He...
According to IHS Markit , the total value of short positions in marijuana stocks has reached an all-time record of $2.1B, influenced by low borrowing costs and increasing share issuance. More news on: GW Pharmaceuticals plc, Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutic...
New York state would gain $435.7M annually in tax revenue for legalized weed, while New York City would get about $336M, according to NYC Comptroller Scott Stringer. More news on: Aurora Cannabis Inc., Aero Grow International, Inc., American Cannabis Company, Inc., Read more ......
IRVINE, CA, May 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that Mr. Raymond C. Dabney, the Company’s President, Chief Executive Officer (CEO), and Co-founder, has been named...
IRVINE, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the second publication of its research results on the use of cannabinoids (CBD’s) to treat various cancers. Th...
IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to issue a 2018 First Quarter Guidance Report and announces court date set for April 20, 2018 in the Company’s ...
IRVINE, CA , March 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it fully supports the Global Hemp Group and the Hemp Farming Act of 2018. Yesterday, Senator Mitch...
IRVINE, CA, March 19, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis Science has acquired Bottle It, Inc., located in Corona, California. Bottle It is Southern C...
News, Short Squeeze, Breakout and More Instantly...
Cannabis Science Inc Company Name:
CBIS Stock Symbol:
OTCMKTS Market:
All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Science Inc., formerly known as (CBIS) per its previous trading history on the OTC Markets Exchange, is...
https://cannabissciencecoin.com/ All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Science Inc., Formerly known as (CBIS) per its previous trading history ...
Have You Heard Of These Marijuana Stocks? The cannabis industry of recent has been tough, to say the least. One day marijuana stocks are up, and the next, the cannabis market is down. Although we as investors are used to this high level of volatility, the past two months have been much mor...